Lu-177 Ludotadipep
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Lu-177 Ludotadipep, covering 2024-04-29 to 2024-04-29. Get the full timeline:
Most recent: Clinical Trial Update: [Lu-177]Ludotadipep in Castration-resistant Prostate Cancer(CRPC): Investigation of Drug and Application_2 [Phase 2]